Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by Red~Oneon May 17, 2022 11:05am
167 Views
Post# 34689187

RE:@Red-One stop this insanity

RE:@Red-One stop this insanityWhisk....maybe one day you and others will admit that when things were good here and then  Farewell announced his intent to R/S the shares....a few of us let all the Longs know that this was a bad idea.

At that point some of the Bagholders with ulterior motives immediately jumped all over us and accused us of being paid bashers, shills, shorters and you name it. All to try and protect their Longterm idea of the company that they had fallen in love with.

Classic transfer of blame for their own blindness to the facts.

I am not a shorter, never have been....been trading small caps stocks for years.

Sorry no "ulterior motive" here....that's something that the paid pumpers and other bagholders cooked up to shift the focus off Farewell...it's classic....Wake Up

There is nothing sinister going on with this stock other than the paid insiders pumping it up....otherwise no traders or investors are interested in CLAS or R107....sorry.
<< Previous
Bullboard Posts
Next >>